58832-36-3

Basic information

• Product Name: 2-Bromofuran-4-carboxylic acid
• Synonyms: 2-Bromofuran-4-carboxylic acid;5-broMofuran-3-carboxylic acid;5-Bromofuran-3-carboxylic acid, 2-Bromo-4-carboxyfuran
• CAS NO: 58832-36-3
• Molecular Formula: C₅H₃BrO₃
• Molecular Weight: 190.97952
• Product Categories: Furan;Halogenated;Organohalides
• Mol File: 58832-36-3.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 279.401 °C at 760 mmHg
• Flash Point: 122.777 °C
• Appearance: /
• Density: 1.892 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.571
• CAS DataBase Reference: 2-Bromofuran-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromofuran-4-carboxylic acid(58832-36-3)
• EPA Substance Registry System: 2-Bromofuran-4-carboxylic acid(58832-36-3)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 58832-36-3(Hazardous Substances Data)

Usage

General Description

2-Bromofuran-4-carboxylic acid is a chemical compound with the molecular formula C6H3BrO3. It is a derivative of furan, a heterocyclic aromatic compound. The presence of a bromine atom and a carboxylic acid group in its structure makes it a valuable intermediate in organic synthesis. It is used in the pharmaceutical industry in the production of various drugs and as a building block for the synthesis of more complex organic compounds. Additionally, it has potential applications in the development of new materials and as a reagent in chemical research. 2-Bromofuran-4-carboxylic acid is a versatile compound with diverse uses in the fields of chemistry and pharmaceuticals.

InChI:InChI=1/C5H3BrO3/c6-4-1-3(2-9-4)5(7)8/h1-2H,(H,7,8)

Upstream product

• 488-93-7 3-Furoic acid 
• 4282-28-4 2,4-furan dicarboxylic acid 
• 67-66-3 chloroform 
• 7726-95-6 bromine 

Downstream Products

• 1333376-24-1 C₂₁H₂₁NO₂ 
• 1333376-23-0 C₁₄H₁₄O₃ 
• 1044852-14-3 5-bromo-N-((1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-3-furancarboxamide 
• 1007197-75-2 5-(4-chlorophenyl)furan-3-carboxylic acid 
• 160084-16-2 2-<(2E,6E)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-7-methyl-3-<(tert-butyldimethylsilyloxy)methyl>-2,6-nonadienyl>-2-<2-trimethylsilylfuran-4-yl>-1,3-dithian 
• 160084-18-4 2-trimethylsilyl-4-<(2E,6E)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-7-methyl-4-hydroxymethyl-1-hydroxy-2,6-nonadien-1-yl>-furan 
• 110202-12-5 2-trimethylsilyl-4-<(3E,7E)-10-(2,6,6-trimethyl-1-cyclohexen-1-yl)-8-methyl-4-formyl-1-hydroxy-3,7-decadien-1-yl>-furan 
• 94742-47-9 (5-Phenylsulfanyl-furan-3-yl)-methanol 

Relevant articles and documents

Thiadiazole amide compound and application thereof

The invention discloses a thiadiazole amide compound and application thereof, and belongs to the field of medicines. The structural general formula of the compound is shown as a formula (I) and is a novel compound with androgen receptor antagonistic activity, wherein one of the key targets is a binding pocket between the androgen receptor ligand binding domain dimer interface. The compound provided by the invention has high activity for antagonizing the transcription of androgen receptor and is at the molecular level. The cell level and the animal level all show good biological activity, and have better safety. , The invention can be applied to the preparation of drugs for treating androgen receptor abnormal expression tumors, including but not limited to prostate cancer, metastatic prostate cancer, castration-resistant prostate cancer, breast cancer and ovarian cancer.

Artificial Ligands of Streptavidin (ALiS): Discovery, Characterization, and Application for Reversible Control of Intracellular Protein Transport

Artificial ligands of streptavidin (ALiS) with association constants of 106 M-1 were discovered by high-throughput screening of our chemical library, and their binding characteristics, including X-ray crystal structure of the streptavidin complex, were determined. Unlike biotin and its derivatives, ALiS exhibits fast dissociation kinetics and excellent cell permeability. The streptavidin-ALiS system provides a novel, practical compound-dependent methodology for repeated reversible cycling of protein localization between intracellular organella.

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula ( I ) represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.